Recent advances in therapies to control diabetes have revolutionized obese patient care 15
Calcium hydroxylapatite (e.g., Radiesse) for more structural support
Weeks 1-4: 0.25 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Weeks 5-8: 0.5 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Weeks 9-12: 1.0 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Weeks 13-16: 1.7 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Week 17 and beyond: 2.4 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Some providers modify this schedule based on individual tolerance
Dietary TMAO decreased glucose tolerance, increased insulin levels and insulin resistance (HOMA-IR), and increased inflammation in mice on a high-fat diet [20]
Plus the overall skin laxity left after the removal of fat will also stay, further accentuating the appearance of cellulite